SAM
TNDM icon

Smartleaf Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Smartleaf Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.96K Hold
440
– – ﹤0.01% 2539
2026
Q1 		$8.62K Sell
440
-890
-67% -$19.3K ﹤0.01% 2397
2025
Q4 		$29.9K Buy
1,330
+593
+80% +$10.7K ﹤0.01% 1813
2025
Q3 		$8.69K Sell
737
-513
-41% -$6.94K ﹤0.01% 2174
2025
Q2 		$23.7K Buy
1,250
+242
+24% +$4.79K ﹤0.01% 1480
2025
Q1 		$19.4K Sell
1,008
-767
-43% -$22.4K ﹤0.01% 1616
2024
Q4 		$65.4K Buy
1,775
+1,101
+163% +$37.2K 0.01% 1045
2024
Q3 		$28.6K Buy
674
+26
+4% +$1.1K ﹤0.01% 1143
2024
Q2 		$26.2K Buy
648
+644
+16,100% +$26.9K ﹤0.01% 932
2024
Q1 		$141 Hold
4
– – ﹤0.01% 1832
2023
Q4 		$0 Buy
+4
New +$83 ﹤0.01% 1231

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Smartleaf Asset Management's TNDM Position: Q2 2026 in Review

Smartleaf Asset Management held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 440 shares worth $6.96K. The position accounts for ﹤0.01% of the portfolio, ranked #2539.

Smartleaf Asset Management first reported a position in TNDM in Q4 2023 and has held it in 11 quarters since. The position peaked at $65.4K in Q4 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Smartleaf Asset Management held 440 shares of Tandem Diabetes Care worth $6.96K as of Q2 2026.
  • Smartleaf Asset Management left its Tandem Diabetes Care share count unchanged in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2539 holding.
  • Smartleaf Asset Management first reported a position in Tandem Diabetes Care in Q4 2023 and has held it in 11 quarters since.
  • Smartleaf Asset Management's Tandem Diabetes Care position peaked at $65.4K in Q4 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.